Scientists wipe out aggressive brain cancer tumors by targeting cellular ‘motors’
A potential treatment for glioblastoma has received approval from the FDA to move to clinical trials.
A potential treatment for glioblastoma has received approval from the FDA to move to clinical trials.
Innovative research at the UF Health Cancer Center is making a meaningful difference for those affected by cancer.
The Zolotukhin Lab at UF is collaborating with researchers at USC to research a genetic therapy for blioblastoma.
The promising strategy could be used in combination with other treatments to increase the effectiveness of glioblastoma therapies.
An mRNA cancer vaccine developed at the University of Florida has attracted widespread news coverage.
The breakthrough by UF Health Cancer Center researchers now will be tested in a Phase 1 pediatric clinical trial for brain cancer.
Researchers developed a new method to evaluate how immunotherapy treatment kills tumor cells.
The study will explore how tumor cells avoid targeting from the immune system.
The study aims to develop a method to enhance the effectiveness of immunotherapy to treat glioblastoma.
With a Florida Department of Health grant, Brent Reynolds, Ph.D., will research a new method of treatment for glioblastoma.